Clinical Trial Update: Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating low-dose ketoconazole in advanced prostate cancer that is resistant to hormone therapy and has prior chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Ketoconazole (Ketoconazole)

Snippet

Sponsor: University of California, Davis | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-02-15